Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 in Moderate to Severe Knee Osteoarthritis (OA)
Clinical trial NCT02095548 · COMPLETED
Trial details
- NCT number
- NCT02095548
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-09-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.